2026 International Spring Forum
April 15, 2026 | 12:00 PM EST
- Home
- Clinical Resources Search
- PQI: clonoSEQ® Next Generation Sequencing for Minimal Residual Disease Testing in Multiple Myeloma
clonoSEQ® Next Generation Sequencing for Minimal Residual Disease Testing in Multiple Myeloma
About this PQI
This document will discuss the utility of the clonoSEQ assay in patients with multiple myeloma by following patients during their treatment.
More About This PQI
PQI in Action Articles:

How to Use a Positive Quality Intervention (PQI)
Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.
Find a PQIFind Similar Resources
All Resources
PQI
PQI
PQI
PQI
PQI: Talectrectinib (Ibtrozi) for the Management of ROS1+ Advanced NSCLC
Author: Stefanie Houseknecht, PharmD, BCOP
Last Updated: 09/01/2025
PQI: Zanidatamab-hrii (Ziihera) for the Management of Biliary Tract Cancer
Author: Shelbie Gibbs, PharmD, BCOP
Last Updated: 09/01/2025
PQI: Prophylaxis and Management of Skin Toxicities with Amivantamab (Rybrevant) and Lazertinib (Lazcluze) Treatment: The COCOON Protocol
Author: Sharon Zhong, PharmD, BCOP
Last Updated: 09/01/2025
PQI: Encorafenib (Braftovi®) and Binimetinib (Mektovi®) for the Management of NSCLC
Author: Aubrey Lasko, PharmD, BCOP
Last Updated: 09/01/2025
PQI in Action
PQI in Action
PQI in Action
PQI in Action
PQI in Action: Fruquintinib (Fruzaqla®)
Author: Florida Cancer Specialists & Research Institute | Atlanticare Cancer Care Institute
Last Updated: 09/01/2025
PQI in Action: Management of Tucatinib (Tukysa®) and Trastuzumab in HER2-Positive Metastatic Colorectal Cancer – 2
Author: Johns Hopkins, MD | The University of Texas MD Anderson Cancer Center, TX
Last Updated: 09/01/2025
PQI in Action: Proactive Symptom Management in Myelofibrosis
Author: Cancer Specialists of North Florida
Last Updated: 09/01/2025
PQI in Action: Sonidegib (Odomzo®) Patient Management
Author: UCLA Medical Center | The Ohio State University Cancer Comprehensive Cancer Center (The James) | WVU Medicine
Last Updated: 09/01/2025
PQI Podcast
PQI Podcast
PQI Podcast
PQI Podcast
S9 E1: Head & Neck Cancer Care: Clinical Progress & Compassionate Practice
Author: Ginger Blackmon, PharmD | Deborah Wong, MD, PhD
Last Updated: 09/01/2025
S8 Bonus Eps 2: Inside ASCO 2025
Author: Ginger Blackmon, PharmD | Kelly Brunk, PharmD, BCOP
Last Updated: 09/01/2025
S8 E15: Supporting Survivors at Work
Author: Ginger Blackmon, PharmD | Rebecca Nellis, MPP
Last Updated: 09/01/2025
S8 E14: Advancing Geriatric Oncology
Author: Ginger Blackmon, PharmD | William Dale, MD, PhD, FASCO
Last Updated: 09/01/2025
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit: Elranatamab
Last Updated: 09/01/2025
Treatment Support Kit: Mirdametinib
Last Updated: 09/01/2025
Treatment Support Kit: Abemaciclib
Last Updated: 09/01/2025
Treatment Support Kit: Temozolomide
Last Updated: 09/01/2025
Video
Video
Video
Video
Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide
Last Updated: 09/01/2025
Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma
Author: Brad Kahl, MD
Last Updated: 09/01/2025
Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications
Author: Jo Ellen Rodgers, PharmD, BCPS, BCCP
Last Updated: 09/01/2025
Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)
Author: Joyce O’Shaughnessy, MD
Last Updated: 09/01/2025
PQI
PQI
PQI in Action
PQI: Advances in MRD Monitoring for Diffuse Large B-Cell Lymphoma (DLBCL)
Author: Tara Graff, DO, MS
Last Updated: 09/01/2025
PQI: clonoSEQ® Next Generation Sequencing for Minimum Residual Disease Testing in Chronic Lymphocytic Leukemia
Author: Eileen Peng, PharmD, MS
Last Updated: 09/01/2025
PQI in Action: ClonoSEQ® Next Generation Sequencing for Minimal Residual Disease Testing in Multiple Myeloma
Author: Florida Cancer Specialists & Research Institute, FL | Rocky Mountain Cancer Centers, CO
Last Updated: 09/01/2025
PQI
PQI
PQI
PQI
PQI: Selinexor (Xpovio®) Patient Management
Author: Jeremiah Moore, PharmD
Last Updated: 09/01/2025
PQI: Ixazomib (Ninlaro®) In the Treatment of Multiple Myeloma
Author: Kirollos Hanna, PharmD, BCPS, BCOP
Last Updated: 09/01/2025
PQI: Isatuximab-irfc (Sarclisa®) Regimens in 1q21 gain/amplification Relapsed/ Refractory Multiple Myeloma
Author: Jeanine Ewing, PharmD, BCOP | Chris Elder, PharmD, BCOP
Last Updated: 09/01/2025
PQI: Isatuximab-irfc (Sarclisa®) In Patients with Relapsed/Refractory Multiple Myeloma
Author: Jon Suyko, PharmD, BCPS
Last Updated: 09/01/2025
PQI
PQI in Action
PQI: clonoSEQ® Next Generation Sequencing for Minimum Residual Disease Testing in Chronic Lymphocytic Leukemia
Author: Eileen Peng, PharmD, MS
Last Updated: 09/01/2025
PQI in Action: ClonoSEQ® Next Generation Sequencing for Minimal Residual Disease Testing in Multiple Myeloma
Author: Florida Cancer Specialists & Research Institute, FL | Rocky Mountain Cancer Centers, CO
Last Updated: 09/01/2025
PQI
PQI Podcast
Treatment Support Kit
PQI
PQI: Talectrectinib (Ibtrozi) for the Management of ROS1+ Advanced NSCLC
Author: Stefanie Houseknecht, PharmD, BCOP
Last Updated: 09/01/2025
S9 E1: Head & Neck Cancer Care: Clinical Progress & Compassionate Practice
Author: Ginger Blackmon, PharmD | Deborah Wong, MD, PhD
Last Updated: 09/01/2025
Treatment Support Kit: Elranatamab
Last Updated: 09/01/2025
PQI: Zanidatamab-hrii (Ziihera) for the Management of Biliary Tract Cancer
Author: Shelbie Gibbs, PharmD, BCOP
Last Updated: 09/01/2025